What is included in long-term monitoring of pediatric mixed connective-tissue disorder (MCTD)?

Updated: Oct 24, 2018
  • Author: Marisa S Klein-Gitelman, MD, MPH; Chief Editor: Lawrence K Jung, MD  more...
  • Print

See the list below:

  • Observe the patient at regular intervals of 1-3 months depending on disease severity and manifestations. Obtain appropriate laboratory tests during these visits depending on disease manifestations and medication adverse effects.

  • Laboratory data may include lupus serology, renal evaluation, muscle enzymes, and hematologic evaluation.

  • Use physical or occupational therapy as needed for musculoskeletal symptoms.

  • Continue to monitor for early evidence of pulmonary hypertension, interstitial lung disease, esophageal dysmotility, and osteoporosis.

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!